Abstract-Thromboxane A 2 (TxA 2 ) causes platelet aggregation, vasoconstriction, and inhibition of endothelial cell (EC) migration and prevents vascular tube formation via its specific receptors (TP), of which there are two isoforms (TP␣ and TP␤), both expressed in human ECs. In this study, we demonstrate that the TxA 2 mimetic IBOP increases apoptosis of human ECs and inhibits the phosphorylation of Akt kinase, an intracellular mediator required for cell survival. TxA 2 -induced functions are mediated by TPs that are members of the G protein-coupled receptor family. Thus far, two TP isoforms have been cloned, one from placenta (TP␣) 10 and one from ECs (TP␤). 11 These isoforms differ in their alternately spliced cytoplasmic C-terminal tails. These tails have an important role in regulating TP signaling and can be phosphorylated (eg, by the cGMP-dependent kinase). 12 The differences in the cytoplasmic domains have been shown to confer association with different G proteins. Although both receptors are linked to G q /G 11 , 13 TP␣ also interacts with G s to stimulate a concomitant increase in cAMP after ligand stimulation, whereas TP␤ causes a ligandinduced decrease in the elevated cAMP level produced by an adenylyl cyclase activator. 14 Recent reports show that the mechanisms and kinetics for desensitization and internalization differ between these two TP isoforms, 15, 16 suggesting that each receptor is linked to a different signal transduction pathway. Whether each receptor triggers a discrete pathway in ECs or mediates distinct EC events is unknown. Recently, we reported that activation of the TP by the TxA 2 mimetics IBOP and U46619 inhibits EC migration in a denudationinjury model and prevents the formation of vascular networks in human umbilical vein ECs (HECs) in vitro, 17 both of which are fundamental events in angiogenesis and in remodeling. Because the balance between positive and negative regulators of EC survival determines vascular formation, we hypothesized that TP stimulation might be involved in the regulation of EC growth or survival. It has been established that activation of the serine/threonine protein kinase Akt, also known as protein kinase B or Rac kinase, is involved in embryonic vascular development and neoangiogenesis, and the phosphatidylinositol 3Ј-kinase (PI3-kinase)/Akt pathways
T he eicosanoid thromboxane A 2 (TxA 2 ) is released from activated platelets, monocytes, and damaged vessel wall and causes platelet aggregation, vasoconstriction, and hypertrophy of vascular smooth muscle. 1,2 TxA 2 and its receptor (TP) are known mediators of unstable coronary disease, 3 acute myocardial infarction, 4 reocclusion after coronary thrombolysis, 5 pregnancy-induced hypertension, 6, 7 and ischemia of multiple organs. 1 The expression of TPs 8, 9 in the vasculature is widespread, but whether TxA 2 affects the growth or survival of endothelial cells (ECs) is unknown.
TxA 2 -induced functions are mediated by TPs that are members of the G protein-coupled receptor family. Thus far, two TP isoforms have been cloned, one from placenta (TP␣) 10 and one from ECs (TP␤). 11 These isoforms differ in their alternately spliced cytoplasmic C-terminal tails. These tails have an important role in regulating TP signaling and can be phosphorylated (eg, by the cGMP-dependent kinase). 12 The differences in the cytoplasmic domains have been shown to confer association with different G proteins. Although both receptors are linked to G q /G 11 , 13 TP␣ also interacts with G s to stimulate a concomitant increase in cAMP after ligand stimulation, whereas TP␤ causes a ligandinduced decrease in the elevated cAMP level produced by an adenylyl cyclase activator. 14 Recent reports show that the mechanisms and kinetics for desensitization and internalization differ between these two TP isoforms, 15, 16 suggesting that each receptor is linked to a different signal transduction pathway. Whether each receptor triggers a discrete pathway in ECs or mediates distinct EC events is unknown. Recently, we reported that activation of the TP by the TxA 2 mimetics IBOP and U46619 inhibits EC migration in a denudationinjury model and prevents the formation of vascular networks in human umbilical vein ECs (HECs) in vitro, 17 both of which are fundamental events in angiogenesis and in remodeling. Because the balance between positive and negative regulators of EC survival determines vascular formation, we hypothesized that TP stimulation might be involved in the regulation of EC growth or survival. It has been established that activation of the serine/threonine protein kinase Akt, also known as protein kinase B or Rac kinase, is involved in embryonic vascular development and neoangiogenesis, and the phosphatidylinositol 3Ј-kinase (PI3-kinase)/Akt pathways are the targets of the antiapoptotic effects of many cytokines and angiogenic growth factors. 18, 19 In this study, we demonstrate that TP stimulation degrades capillary formation in ECs in vitro, and that TP stimulation induces EC apoptosis and inhibits phosphorylation of the survival protein kinase Akt. Furthermore, TP isoforms differ in the signal transduction pathway used to cause apoptosis.
Materials and Methods

Materials, Cell Culture, and Stable Lines of Rat Capillary ECs (RECs)
The TxA 2 mimetic IBOP and antagonist SQ29548 were purchased from Cayman Chemical. [ 3 H]SQ29548 was from NEN Life Science. Forskolin, protein kinase A (PKA) inhibitor 14-22 amide, and H-89 were obtained from Calbiochem. HECs were isolated and cultured until the third passage in M199 containing 20% newborn calf serum and 5% human serum. 17 RECs were cultured in M199 with 15% FBS. 20 Differential expression plasmids (the GFP/pRc plasmid 21 ) containing TP␣ or TP␤ cDNA were constructed. RECs were transfected with vector, TP␣, or TP␤ construct using lipofectin (Gibco BRL). Stable clones were selected by neomycin and sorted by GFP fluorescence using a FACScan flow cytometer. Expression of TP was determined by reverse transcription-polymerase chain reaction (RT-PCR) using SuperScript One-Step RT-PCR kit (Gibco BRL). A sense primer, 3AF, AGACAGTGCTGCGAAACCCG (nucleotides 800 to 819), corresponding to the conserved region, and three antisense primers were used, 3BR, TCTTCCAATGTCTG-CATGCCC (nucleotides 1315 to 1295) in the TP␣-specific region, and 3CR, TGTAATCCCAGCTGCTCGGGA (nucleotides 1764 to 1745), and 4AS, GGAGTCTCACTCTGTGGCCCA (nucleotides 1006 to 987), representing the portion of the cytoplasmic tail common to both isoforms after TP␣-specific region. TP binding sites were determined as described. 15 [Ca 2ϩ ] i responding to IBOP stimulation was measured using fura 2-based digital imaging microscopy as described. 22 In Vitro Tube Formation Assay Cells (1.5ϫ10 5 /well) were seeded on Matrigel in 12-well plates for 13 hours to allow tube formation, then stimulated with different concentrations of IBOP alone or plus SQ29548 for an additional 24 hours. The number of enclosed networks of tubes was determined as described. 17 Incomplete networks were not counted.
Analysis of EC Apoptosis
Cells (1ϫ10 6 ) were harvested and stained by either fluorescein isothiocyanate-conjugated annexin V (for HECs) or annexin V-biotin/streptavidin-allophycocyanin (for RECs) and propidium iodide dye following the manufacturer's protocol (PharMingen). Apoptotic cells were determined by flow cytometry. For morphology, HECs on Matrigel were stained in situ with Hoechst 33342 for 10 minutes and fixed with 3.7% formaldehyde in PBS for 15 minutes. Images were captured using a Nikon Eclipse 600 microscope with a Nikon Coolpix 950 digital camera attached. For quantification of apoptotic cells, tubular networks formed on Matrigel were liberated by dispase (1 mL/well) digestion for 2 hours. The 
Akt Phosphorylation Assay
Akt phosphorylation was analyzed with the phosphospecific Akt (Ser473) antibody (New England BioLabs) by Western blotting. 21 cAMP Enzyme Immunoassay (EIA) Measurement cAMP measurements of the cell lysates were performed by an enzyme immunoassay (EIA) according to the manufacturer's instruction (Amersham).
Statistical Analysis
One-or two-way ANOVA was performed. Post hoc test was performed by Fisher's least significant difference method. Differences were considered significant at values of PϽ0.01.
Results
Expression of TP Isoforms in HEC and REC Clones
Using RT-PCR, we have determined that HECs express both TP isoforms ( Figure 1A , left), consistent with a previous report. 9 To determine whether TP isoforms mediate different aspects of TP function, each TP isoform was expressed in RECs (which are TP-null) to create separate clones of TP␣ and TP␤ ( Figure 1A , right). Scatchard analysis ( Figure 1B 
Reversal of Angiogenesis In Vitro and Apoptosis of HECs by TxA 2
HECs were incubated with IBOP on the Matrigel as described in Materials and Methods. Loss of preformed EC tubes after IBOP treatment was observed in a concentration-dependent manner. This degradation of the tubes was specifically prevented by the TP antagonist SQ29548 (Figure 2A ), indicating that this effect resulted from stimulation of the TP. A representative experiment of degradation of EC tubes on the Matrigel is shown in Figure 2B . To determine whether IBOP-induced apoptosis might be the cause, we examined whether IBOP-treated ECs demonstrated evidence of apoptosis. IBOP increased HEC apoptosis 2-fold after 24 hours ( Figure 3A , left) and Ͼ3-fold after 48 hours ( Figure 3A , right), as determined by flow cytometry. The TP antagonist SQ29548 (Figure 3 ) also blocked these effects. Apoptosis of HECs from Matrigel was determined morphologically by Hoechst 33342 stain and also by flow cytometry. IBOPtreated HECs from Matrigel did not form tubes and exhibited a random arrangement of cells with either condensed or fragmented nuclei ( Figure 3B ), which were considered apoptotic, and the number of apoptotic cells was increased 55% compared with untreated cells ( Figure 3C ). Thus, IBOP mediated the degradation of preformed capillary tubes in vitro and induced apoptosis in HECs.
Reversal of Angiogenesis In Vitro and Apoptosis in REC TP␣ and TP␤ by TxA 2
To determine whether the TP isoforms had different effects in IBOP-induced tube degradation and apoptosis, we tested whether IBOP causes tube degradation and apoptosis in only TP␣ ECs or TP␤ ECs or both. IBOP degraded formed tubes and induced apoptosis in both TP␣ and TP␤ ECs, which was specifically blocked by SQ29548 (Figures 4 and 5) . Vectortransfected cells did not show tube degradation or increased apoptosis with IBOP. Thus, these results suggest that either TP isoform can mediate IBOP-induced reversal of angiogenesis in vitro and EC apoptosis.
TxA 2 Inhibits Phosphorylation of Akt Kinase
Given that the Akt signal pathway is an important determinant of EC survival, we determined whether IBOP induces apoptosis by counteracting serum-induced Akt activation. Akt phosphorylation was analyzed by Western blotting with a specific phospho-Akt antibody, which has been shown to correlate with its enzyme activity. 19 In the presence of serum, apoptosis is inhibited and Akt is phosphorylated and activated. Stimulation with IBOP in HECs ( Figure 6A ) and in RECs expressing either TP isoform ( Figure 6B ) markedly decreased the amount of phosphorylated Akt. TP antagonist SQ29548 specifically blocked the dephosphorylation of Akt by IBOP. These results suggest that IBOP induces apoptosis in ECs, probably via inhibiting the Akt signal transduction pathway. Previous reports suggested that the TP isoforms have distinct effects on cAMP metabolism, 14 and changes in cAMP levels are associated with apoptosis in different kinds of cells. [23] [24] [25] [26] Thus, we determined whether the cAMP-dependent pathway contributes to IBOP-induced apoptosis by each TP isoform. Figure 7 demonstrates a differential response in cAMP levels after IBOP in each of the ECs. TP␣ ECs showed a concentration-dependent increase in cAMP levels, whereas neither TP␤ ECs nor vector ECs showed a significant change in cAMP levels. To test whether modification of the cAMP pathway affects apoptosis in either TP␣ or TP␤ ECs, cells were treated with either the adenylyl cyclase activator forskolin or the cell-permeable myristoylated PKA inhibitor 14-22 amide and H-89. Neither forskolin nor the two PKA inhibitors affected IBOP-induced apoptosis in TP␣ cells ( Figure 8A ). On the other hand, forskolin suppressed IBOP- induced apoptosis, and both of the PKA inhibitors enhanced IBOP-induced apoptosis in TP␤ cells ( Figure 8B ). These results suggest that the inhibition of adenylyl cyclase by TP␤ stimulation may have an important role in inducing EC apoptosis, but that TP␣ stimulation, although it affects cAMP metabolism, may induce apoptosis by a separate mechanism.
Discussion
TxA 2 contributes to thrombosis and ischemia by causing aggregation of platelets and vasoconstriction, 1 and TxA 2 levels are elevated during those states. 3, 6 Thus, any effects that TxA 2 has on endothelial function or angiogenesis would be relevant in patients with ischemia. In this study, we demonstrated that in vitro tube formation in HECs was reversed with the TxA 2 mimetic, an effect that resulted from its interaction with TP and may reflect EC apoptosis. These results suggest that TxA 2 may prevent and reverse angiogenesis via EC apoptosis during conditions such as myocardial infarction or myocarditis in which TxA 2 is formed and released from platelets or macrophages. 27 By suppressing angiogenesis, TxA 2 might also affect the vascular remodeling process.
What is the mechanism(s) by which TP stimulation induces apoptosis and reverses vascular tube formation? One possibility is that EC tubes on Matrigel require growth factors, such as basic fibroblast growth factor (FGF), for their maintenance and survival. Reversal of angiogenesis was recently noted in HECs after deprivation of basic FGF, which was followed by apoptosis. 28 Increasing evidence of crosstalk Figure 5 . Induction of apoptosis by IBOP in TP␣ or TP␤ ECs. RECs were serum-deprived for 2 days, then stimulated with or without IBOP (100 nmol/L) or IBOP with SQ29548 (5 mol/L) for 24 hours in serum-free medium. Tumor necrosis factor-␣ (TNF-␣) (100 U/mL) and cycloheximide (CHX) (2.5 g/mL) were added as a positive control for apoptosis. After stimulation, cells both in the media and on the bottom of the dishes were collected. Apoptotic cells were determined as described in Materials and Methods. Results shown are meanϮSE of 3 independent experiments. # PϽ0.001 vs control or IBOP in vector; *PϽ0.01 vs control or IBOP with SQ29548 in TP␣ and TP␤. between G protein and tyrosine kinase receptors 29 suggests that one of the possible mechanisms for our observations is that TxA 2 -derived signals may interact with and inhibit such a growth factor survival signaling pathway.
A second possibility, not necessarily mutually exclusive, is based on the effect of TxA 2 on Akt. Akt is a growth factor-regulated serine/threonine kinase that contains a pleckstrin homology (PH) domain and is activated by a mechanism involving PI3-kinase. Binding of PI3-kinase products to the PH domain results in translocation of Akt to the plasma membrane where it is activated by phosphorylation by upstream kinases including PI3-kinase. Activated Akt provides a universal survival signal to protect cells from apoptosis induced by various stresses. 19, 30 In this study, we have demonstrated that IBOP markedly reduces the phosphorylation of Akt in ECs. Phosphorylation of Akt correlates with its kinase activity, which, in turn, is proportional to its ability to inhibit apoptosis and promote survival. 19, 31 Thus, these results suggest that TxA 2 may induce apoptosis by inhibiting the Akt signal pathway.
As noted above, human TP exists as at least two isoforms (TP␣ and TP␤). Both isoforms are expressed in a number of tissues and cells including platelets, placenta, and ECs. To test the differential role of TP isoforms in mediating EC apoptosis, we expressed each isoform in RECs, which have no native functional TP. Both TP␣ and TP␤ ECs showed enhanced apoptosis and decreased phospho-Akt level after IBOP stimulation, suggesting that both TP isoforms mediate EC apoptosis, although it is not clear how these isoforms are regulated in vivo.
The next hypothesis that we tested is that the TP isoforms induced apoptosis using different intracellular mediators. Each TP isoform uses a signaling pathway with some features that are shared, and at least some that differ. Hirata et al 14 reported that in human platelets TP␣ was functionally coupled to G s whereas TP␤ was coupled to G i . Thus, in addition to differences in desensitization 15 and internalization, 16 the TP isoforms have contrasting effects on cAMP mobilization.
There are data to suggest that these changes in cAMP may be related to the ability of TxA 2 to induce apoptosis; in tissues other than ECs, such changes in cAMP levels have been linked to this process. No consistent direction for the association of cAMP changes with apoptosis has been established. In some cases, increased cAMP promotes, 23, 24 and in others prevents, 25, 26 apoptosis. In vascular ECs, TxA 2 causes vascular EC damage (as estimated by adenine release), and a phosphodiesterase inhibitor, which increases cAMP levels, prevents this TxA 2 -induced damage, although whether the effects of TxA 2 resulted from apoptosis in that study is unknown. 32 In the present study, we sought to determine whether PKA inhibition could be responsible for the apoptosis in TP␤ ECs, or whether PKA activation could mediate IBOP-induced apoptosis in TP␣ ECs. The adenylyl cyclase activator forskolin suppressed and the PKA inhibitors increased TxA 2 -induced apoptosis in TP␤, suggesting that the inhibition of PKA (a decrease of the cAMP level) may promote apoptosis in these cells. On the other hand, the PKA inhibitors did not block TxA 2 -induced apoptosis in TP␣, nor was such apoptosis enhanced by forskolin. These results indicate that PKA inhibition induced by the TP␤ isoform might mediate the proapoptotic effect of TP, but that PKA activation induced by the TP␣ might not be related to apoptosis in ECs. These data suggest that stimulation of each TP isoform may induce apoptosis via a different downstream pathway, only one of which (TP␤) appears to be associated with cAMP.
In disease states such as myocardial infarction and pregnancy-induced hypertension, an elevated number of TPs has been found in platelets, 4, 7 and there are also increased levels of circulating TxA 2 . 3, 6 Our finding that TxA 2 damages ECs suggests that the eicosanoid might further aggravate these diseases by lessening the thromboresistant and vasodilatory properties of ECs. In addition, TxA 2 might prevent and reverse angiogenesis or collateral development in ischemic hearts, a process that protects hearts from further ischemia and promotes recovery. 33 Thus, we speculate that a TxA 2 receptor blocker and/or TxA 2 synthase inhibitor might promote angiogenesis and improve the process of remodeling of the tissue over several weeks.
In conclusion, we demonstrate TP-mediated reversal of tube formation in vitro and also a possible mechanism for this phenomenon: TP-mediated apoptosis of HECs at least par- Figure 8 . Effect of forskolin, PKA inhibitor (PKAI), and H-89 on IBOP-induced apoptosis in TP␣ or TP␤ ECs. Cells were serum-deprived for 2 days, then stimulated with different reagents as indicated for 24 hours in serum-free medium. TNF-␣ (100 U/mL) and CHX (2.5 g/mL) were added as a positive control for apoptosis. After stimulation, cells both in the media and on the bottom of the dishes were collected. Apoptotic cells were determined by flow cytometry for annexin V and propidium iodide staining. A, Forskolin (FSK) (10 mol/L), PKAI (1 mol/L), and H-89 (1 mol/L) had no effect on IBOP (100 mol/L)-induced apoptosis in TP␣ ECs. B, FSK decreased and PKAI and H-89 increased IBOPinduced apoptosis in TP␤ ECs. Three experiments were performed using 2 different clones from each isoform.
# PϽ0.001 vs vector control; *PϽ0.01 vs TP␣ control; ⌬PϽ0.01 vs TP␤ control and IBOPϩFSK.
tially through dephosphorylation of Akt kinase. TP isoforms mediate apoptosis through at least two separate signal transduction pathways. These observations suggest that TP stimulation of ECs may have an important effect on pathophysiological conditions marked by TxA 2 release that requires vascular growth or repair.
